CIK 0000310158 · Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 221918501
- Phone
- 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-27 | Oosthuizen Johannes Jacobus President, U.S. Market | Grant or award | +8,664 | $97.94 | $849K | 32,607.47 |
| 2025-01-27 | Litchfield Caroline EVP & CFO | Grant or award | +23,432 | $97.94 | $2.3M | 74,340.19 |
| 2025-01-27 | Li Dean Y Executive VP & President, MRL | Grant or award | +32,621 | $97.94 | $3.2M | 79,592.15 |
| 2025-01-27 | Downing Cristal N Chief Comm. & Public Afrs Ofcr | Grant or award | +9,446 | $97.94 | $925K | 9,446 |
| 2025-01-27 | DeLuca Richard R. EVP&Pres, Merck Animal Heallth | Grant or award | +25,438 | $97.94 | $2.5M | 178,992.71 |
| 2025-01-27 | Davis Robert M Chairman, CEO & President | Grant or award | +95,275 | $97.94 | $9.3M | 443,601.76 |
| 2025-01-27 | Chattopadhyay Sanat Exe V-P & Pres. MMD | Grant or award | +28,136 | $97.94 | $2.8M | 78,758 |
| 2025-01-27 | Guindo Chirfi Chief Marketing Officer | Grant or award | +28,158 | $97.94 | $2.8M | 69,143.92 |
| 2025-01-01 | Karsanbhai Surendralal Lanca Director | Grant or award · Phantom Stock | +552.87 | $99.48 | $55K | 552.87 |
| 2024-12-31 | Seidman Christine E Director | Grant or award · Phantom Stock | +81.67 | $99.48 | $8K | 15,164.74 |
| 2024-12-31 | GLOCER THOMAS H Director | Grant or award · Phantom Stock | +490.05 | $99.48 | $49K | 98,246.67 |
| 2024-12-31 | Coe Mary Ellen Director | Grant or award · Phantom Stock | +301.57 | $99.48 | $30K | 24,041.08 |
| 2024-09-30 | Seidman Christine E Director | Grant or award · Phantom Stock | +71.55 | $113.56 | $8K | 14,977.37 |
| 2024-09-30 | GLOCER THOMAS H Director | Grant or award · Phantom Stock | +429.29 | $113.56 | $49K | 97,074.95 |
| 2024-09-30 | Coe Mary Ellen Director | Grant or award · Phantom Stock | +264.18 | $113.56 | $30K | 23,574.22 |
| 2024-08-05 | Guindo Chirfi Chief Marketing Officer | Option exercise | +36,901 | $115.20 | $4.3M | 57,781.59 |
| 2024-08-05 | Guindo Chirfi Chief Marketing Officer | Shares withheld for taxes | −17,412 | $115.20 | $2.0M | 40,369.59 |
| 2024-08-05 | Guindo Chirfi Chief Marketing Officer | Option exercise · Restricted Stock Unit | −36,901 | 36,903 | ||
| 2024-06-28 | Seidman Christine E Director | Grant or award · Phantom Stock | +65.63 | $123.80 | $8K | 14,815.52 |
| 2024-06-28 | GLOCER THOMAS H Director | Grant or award · Phantom Stock | +393.78 | $123.80 | $49K | 96,063.14 |
Page 14 of 19 · 376 trades